• Our Members
  • Events
  • Contact us
AMR Industry Alliance
  • About us
    • Why the AMR Industry Alliance?
    • Board Members
  • Shared Goals
    • AMR Industry Declaration
    • Industry Roadmap for Progress on Combating Antimicrobial Resistance
    • Responsible Manufacturing
    • 2026 Stewardship Prize
  • Why AMR?
  • Newsroom
  • Progress Report
  • In Action
Select Page
CAL02

CAL02

by mcwebmaster | Jan 9, 2018

Prevention of Post-Surgical Staphylococcal Infections.

Prevention of Post-Surgical Staphylococcal Infections.

by mcwebmaster | Jan 9, 2018

SIRTURO® (bedaquiline) Development and Launch

SIRTURO® (bedaquiline) Development and Launch

by mcwebmaster | Dec 21, 2017

BEAM Alliance – Guidelines as to how antibacterial R&D could be revived and proposes specific support for SME-driven innovation in the AMR field.

BEAM Alliance – Guidelines as to how antibacterial R&D could be revived and proposes specific support for SME-driven innovation in the AMR field.

by mcwebmaster | Dec 21, 2017

AiCuris Initiates Clinical Development of AIC499, a Novel Resistance-Breaking Antibiotic against a Broad Range of MDR Gram-Negative Bacteria

AiCuris Initiates Clinical Development of AIC499, a Novel Resistance-Breaking Antibiotic against a Broad Range of MDR Gram-Negative Bacteria

by mcwebmaster | Dec 19, 2017

« Older Entries

stay informed

Subscribe to receive our updates

about us

The AMR Industry Alliance brings together biotech, diagnostics, generics and research-based pharmaceutical companies, to drive and measure industry progress to curb antimicrobial resistance.

read more
contact

AMR Industry Alliance Secretariat (IFPMA)
Chemin des Mines 9
P.O. Box 195
1211 Geneva 20
Switzerland
Email: info@amrindustryalliance.org

© AMR Industry Alliance 2017 - Contact us - Cookies Policy - Privacy Policy - Terms of use - Privacy Centre - Careers